Mehul Jhaveri

All-Cause Health Care Utilization and Costs Associated with Newly Diagnosed Multiple Sclerosis in the United States

Carl V. Asche, Mendel E. Singer, Mehul Jhaveri et al. · Journal of Managed Care Pharmacy · 2010 · 107 citations · Full text

Pharmacy, Neurology, Pharmacoeconomics +17

Comparative effectiveness of dimethyl fumarate versus fingolimod and teriflunomide among MS patients switching from first-generation platform therapies in the US

Daniel Ontaneda, Jacqueline Nicholas, Matthew Carraro et al. · Multiple Sclerosis and Related Disorders · 2018 · 58 citations

Pharmacy, Pharmacotherapy, Clinical Pharmacology +16

Predictors of Progression of Recently Diagnosed Atrial Fibrillation in REgistry on Cardiac Rhythm DisORDers Assessing the Control of Atrial Fibrillation (RecordAF)–United States Cohort

Yuanyuan Zhang, Chunfu Qiu, Pamela J. Davis et al. · The American Journal of Cardiology · 2013 · 55 citations

Medicine, Cardiology, Clinical Sciences +6

Hospital Readmissions in US Atrial Fibrillation Patients

Alpesh Amin, Mehul Jhaveri, Jay Lin · American Journal of Therapeutics · 2012 · 27 citations

Medicine, Cardiology, Pharmacoeconomics +16

Burden, timing, and relationship of cardiovascular hospitalization to mortality among Medicare beneficiaries with newly diagnosed atrial fibrillation

Mintu P. Turakhia, Matthew D. Solomon, Mehul Jhaveri et al. · American Heart Journal · 2013 · 24 citations

Medicine, Cardiology, Internal Medicine +10